advanc
sarscov
research
overwhelm
viru
becom
one
studi
among
coronavirus
spite
extens
studi
pathogenesi
mechan
develop
sever
respiratori
diseas
yet
fulli
elucid
although
number
anim
speci
found
permit
sarscov
replic
limit
success
develop
histopatholog
similar
human
sar
anim
model
recent
transgen
mice
express
human
report
develop
pneumonia
sarscov
infect
pathogenesi
sarscov
infect
mice
howev
slightli
differ
human
sar
human
sar
patient
gener
die
pulmonari
failur
wherea
infect
central
nervou
system
major
factor
respons
fatal
outcom
transgen
mice
anoth
transgen
model
high
replic
sarscov
brain
like
contribut
death
recent
robert
et
al
report
mouseadapt
sarscov
caus
fatal
respiratori
diseas
young
mice
reproduc
mani
aspect
human
sar
respiratori
agent
human
metapneumoviru
chlamydia
isol
sar
patient
initi
suspect
caus
agent
sar
howev
sarscov
final
identifi
agent
sar
sinc
fulfil
koch
postul
nevertheless
anim
infect
sarscov
alon
fail
develop
sarslik
sever
pneumonia
result
may
impli
respiratori
agent
found
sar
case
could
work
combin
sarscov
order
induc
sever
form
pneumonia
cours
studi
cell
entri
mechanismt
sarscov
found
proteas
produc
host
anim
trypsin
elastas
enhanc
sarscov
infect
cultur
cell
vitro
observ
hint
highli
pathogen
featur
viru
lung
elastas
predominantli
produc
result
inflamm
present
studi
examin
whether
sarscov
infect
enhanc
weak
inflamm
lung
induc
infect
lowpathogen
bacteria
induc
elastas
result
show
lowvirul
pp
infect
administr
lp
deriv
escherichia
coli
induc
elastas
lung
enhanc
replic
sarscov
result
exacerb
respiratori
diseas
caus
sarscov
infect
high
mortal
rate
result
indic
coinfect
sarscov
lowvirul
microorgan
induc
exacerb
pneumonia
suggest
possibl
elastas
involv
pathogenesi
exacerb
pneumonia
caus
sarscov
infect
kindli
provid
dr
john
ziebuhr
well
frmo
propag
plaqu
assay
cell
previous
describ
compar
origin
viru
use
laboratori
two
amino
acid
chang
posit
tyr
protein
ala
ser
presum
arisen
passag
cell
passag
mice
obtain
frmo
done
follow
mice
inocul
lung
wash
pb
ph
contain
bovin
serum
albumin
sigma
st
loui
mo
usa
iu
penicillin
g
sigma
streptomycin
sigma
amphotericin
b
gibco
grand
island
ny
usa
per
ml
day
three
infect
result
bronchoalveolar
wash
inocul
mice
rout
passag
total
time
final
lung
infect
mice
homogen
homogen
spun
rpm
minut
c
supernat
inocul
onto
cell
cultur
fluid
infect
cell
use
infect
mice
frmo
aminoacid
mutat
protein
posit
asp
glu
well
tyr
latter
ident
mutat
found
frmo
two
addit
mutat
phe
leu
thr
ile
though
mutat
found
present
titrat
viru
lung
asept
isol
interv
inocul
homogen
prepar
use
grinder
silica
sand
chill
pb
contain
ml
kanamycin
meijiseika
tokyo
japan
homogen
centrifug
rpm
minut
c
supernat
isol
kept
c
viru
titrat
cell
grown
maintain
dmem
nissui
tokyo
japan
contain
fc
sigma
viru
infect
determin
plaqu
assay
describ
previous
sixweekold
balbc
male
mice
purchas
slc
hamamatsu
japan
charl
river
japan
crj
tokyo
japan
mice
serolog
confirm
free
infect
pathogen
microorgan
includ
pp
mice
anesthet
intraperiton
administr
xylazin
ketamin
inocul
pp
mam
strain
suspend
pb
experi
mice
administ
lp
sigma
dissolv
pb
concentr
mgml
mice
inocul
srascov
one
day
pp
infect
lp
administr
kept
globe
box
isol
bsl
laboratori
institut
experiment
period
mice
kill
select
interv
sarscov
infect
lung
organ
asept
collect
viru
titrat
histopatholog
examin
detect
virusspecif
antigen
measur
elastas
activ
mice
maintain
keep
anim
experi
guidelin
institut
mice
inocul
pp
andor
sarscov
kill
select
interv
infect
tissu
mice
fix
neutral
buffer
formalin
ph
subject
routin
patholog
examin
detect
viru
antigen
streptavidinbiotin
complex
method
dako
japan
use
rabbit
hyperimmun
serum
produc
institut
sarscov
accord
manufactur
instruct
elastas
activ
examin
use
synthet
substrat
sucalaalaprovalpna
highli
specif
neutrophil
elastas
lung
tissu
describ
yoshimura
et
al
determin
elastas
activ
employ
lung
homogen
prepar
describ
bal
collect
bal
one
ml
chill
salin
contain
citric
acid
inject
lung
dead
mice
via
trachea
use
canula
combin
syring
salin
recov
remov
cell
contain
bal
spin
rpm
five
minut
supernat
use
determin
elastas
activ
lung
homogen
dilut
pb
final
lung
homogen
bal
incub
trishcl
buffer
ph
contain
nacl
mm
substrat
hour
c
pna
releas
substrat
measur
spectrophotometr
nm
shown
elastas
activ
describ
previous
cytokin
chemokin
assay
mostli
previous
report
lung
homogen
prepar
describ
dilut
time
lysi
buffer
virus
includ
materi
complet
inactiv
ultraviolet
irradi
minut
use
mous
cytokin
plex
antibodi
bead
kit
bioscienc
intern
inc
camarillo
ca
usa
previous
report
materi
examin
luminex
luminex
co
austin
tx
usa
follow
cytokin
chemokin
fgf
basic
gmcsf
kc
mig
vegf
shown
sarscov
replic
enhanc
presenc
proteas
trypsin
elastas
possibl
molecular
mechan
enhanc
potenti
sarscov
infect
cell
surfac
effici
infect
via
endosom
pathway
take
place
absenc
proteas
elastas
major
proteas
produc
lung
inflamm
could
enhanc
sarscov
replic
lung
would
turn
result
sever
damag
organ
first
examin
whether
infect
pp
induc
elastas
lung
pp
low
virul
rule
caus
mild
never
sever
respiratori
diseas
adult
mice
sixweekold
balbc
mice
infect
cfu
pp
elastas
activ
lung
homogen
bal
monitor
one
day
pi
signific
amount
elastas
detect
bal
lung
ppinfect
mice
elastas
activ
undetect
sampl
uninfect
mice
fig
also
examin
effect
lp
administr
elastas
product
lung
sinc
lp
use
elastas
induc
mice
administ
lp
mgml
dissolv
pb
shown
produc
elastas
lung
one
two
day
administr
similar
infect
pp
fig
result
show
pp
lp
appropri
agent
induc
elastas
lung
bal
next
examin
effect
pp
sarscov
infect
use
two
differ
sarscov
one
isol
diseas
human
mouseadapt
viru
call
frmo
passag
time
mice
final
grown
cell
describ
materi
method
frmo
four
amino
acid
chang
spike
compar
report
previous
mice
infect
cfu
pp
one
day
later
coinfect
pfu
frmo
respect
rout
shown
two
six
mice
infect
withpp
frmo
die
day
five
pi
bodi
weight
day
five
seven
pi
show
signific
differ
compar
ppinfect
mice
p
p
p
student
test
b
three
six
mice
treat
lp
infect
frmo
die
day
four
bodi
weight
significantli
lower
p
day
three
four
comparison
mice
treat
lp
alon
c
fig
contrast
mice
coinfect
withpp
frmo
sever
weight
loss
recov
observ
period
eight
day
pi
fig
bodi
weight
mice
die
exhibit
sever
respiratori
diseas
thu
mice
coinfect
pp
frmo
develop
sever
respiratori
diseas
suggest
possibl
elastas
produc
pp
infect
exacerb
infect
sarscov
adapt
mice
also
infect
mice
administ
lp
frmo
fig
mice
develop
weight
loss
clinic
symptom
similar
display
mice
inocul
pp
frmo
onehalf
infect
mice
die
day
four
pi
remain
mice
gradual
recov
fig
find
also
support
possibl
elastas
involv
exacerb
respiratori
diseas
caus
sarscov
infect
examin
viru
titer
mice
infect
sarscov
alon
doubli
infect
pp
sarscov
mice
infect
condit
ident
shown
figur
examin
day
two
four
pi
frmo
grown
rate
higher
lung
mice
fig
b
show
frmo
higher
potenti
grow
mice
day
two
pi
viru
titer
lung
higher
mice
infect
pp
mice
infect
alon
howev
fourth
day
pi
signific
differ
two
group
fig
day
two
pi
viru
titer
mice
infect
pp
frmo
slightli
significantli
higher
mice
infect
frmo
alon
differ
viru
titer
mice
infect
pp
frmo
frmo
alon
also
evid
four
day
pi
fig
result
show
infect
pp
greatli
enhanc
infect
less
remark
effect
infect
frmo
earli
phase
viral
infect
signific
enhanc
frmo
infect
observ
mice
infect
low
titer
viru
mice
infect
pfu
viru
titer
higher
mice
coinfect
pp
frmo
infect
frmo
alon
two
four
day
pi
fig
enhanc
frmo
infect
lung
also
observ
mice
receiv
lp
compar
mice
without
lp
administr
data
shown
result
collect
suggest
elastas
induc
pp
infect
lp
administr
enhanc
infect
produc
mouseadapt
frmo
mous
lung
elastas
activ
mice
infect
pp
frmo
pp
frmo
pp
alon
examin
day
two
four
sarscov
infect
three
five
day
pp
infect
shown
figur
lung
elastas
activ
mice
infect
pp
significantli
higher
mice
infect
pp
examin
day
two
day
four
sarscov
infect
also
clear
neither
frmo
elicit
elastas
data
togeth
find
viru
titer
lung
shown
figur
b
indic
possibl
elastas
produc
lung
follow
pp
infect
effici
enhanc
infect
effici
less
still
significantli
enhanc
frmo
infect
howev
slightli
higher
titer
found
four
day
pi
lung
mice
infect
pp
frmo
could
explain
direct
influenc
elastas
frmo
infect
lung
import
condit
sustain
high
titer
beyond
four
day
pi
would
high
replic
lung
earli
phase
infect
could
facilit
elastas
induc
pp
data
suggest
sever
respiratori
diseas
caus
coinfect
pp
mouseadapt
sarscov
attribut
high
replic
viru
lung
elastas
produc
pp
infect
probabl
respons
develop
sever
pneumonia
infect
mice
due
high
growth
pp
lung
sinc
almost
bacteria
detect
mice
coinfect
pp
sarscov
day
four
pp
infect
similar
find
infect
pp
alon
also
examin
infecti
viru
titer
variou
organ
lung
blood
liver
spleen
heart
intestin
brain
mice
doubli
infect
pp
frmo
contain
infecti
virus
significantli
higher
mg
tissu
indic
frmo
fail
grow
organ
lung
sinc
involv
cytokin
pathogenesi
sar
describ
measur
level
number
cytokin
lung
mice
infect
frmo
alon
fail
develop
sever
pneumonia
lung
coinfect
pp
frmo
show
exacerb
pneumonia
shown
figur
significantli
higher
level
product
two
cytokin
fig
mig
fig
encount
latter
mice
day
two
pi
later
day
four
fig
also
significantli
higher
pp
frmo
infect
mice
p
howev
signific
differ
pp
infect
mice
infect
pp
frmo
p
level
infect
frmo
doubli
infect
mice
result
could
suggest
involv
two
cytokin
high
pathogenesi
caus
coinfect
pp
sarscov
examin
histopatholog
chang
lung
mice
viru
titer
measur
shown
figur
mice
infect
pp
alon
show
consolid
neutrophil
macrophag
accumul
lesion
cure
week
mice
infect
sarscov
alon
infiltr
inflammatori
mononuclear
cell
alveolar
wall
coinfect
mice
display
lesion
earli
phase
infect
day
four
pi
pp
frmoinfect
mice
show
plentitud
eosinophil
hyalin
substanc
caviti
fill
necrot
cell
debri
alveolar
macrophag
well
hyperplast
chang
type
respiratori
epithelium
fig
although
chang
alveoli
hardli
observ
mice
infect
frmo
alon
fig
viral
antigen
detect
cytoplasm
type
respiratori
epitheli
cell
well
exfoli
bronchoepitheli
cell
alveolar
caviti
fig
coinfect
mice
die
day
four
six
display
diffus
alveolar
damag
sever
congest
diffus
exud
hyalin
substanc
alveolar
caviti
low
inflammatori
cell
infiltr
type
respiratori
epitheli
cell
activ
fig
e
reminisc
seen
case
ard
report
follow
autopsi
victim
latest
sar
epidem
thu
great
histopatholog
similar
found
exist
mice
infect
pp
frmo
sar
case
report
sever
report
mice
suscept
sarscov
infect
also
show
diseas
caus
viral
infect
asymptomat
transient
replic
viru
took
place
lung
mice
also
except
mani
speci
anim
shown
suscept
sarscov
infect
develop
exacerb
respiratori
diseas
present
studi
show
could
induc
sever
respiratori
diseas
mice
resembl
found
human
sarscov
infect
mice
coinfect
lowvirul
respiratori
bacterium
pp
sarscov
develop
sever
pneumonia
infect
mice
die
present
studi
indic
two
condit
critic
establish
sever
diseas
document
import
develop
sar
one
enhanc
sarscov
infect
proteas
produc
host
cell
evolut
sarscov
extent
becom
highli
infecti
pathogen
given
speci
anim
sarscov
adapt
two
condit
fulfil
sever
respiratori
diseas
reproduc
robert
et
al
describ
sarscov
adapt
mice
serial
passag
origin
urbani
strain
mous
lung
acquir
high
virul
mice
mouseadapt
viru
sever
genet
mutat
accompani
amino
acid
mutat
also
gene
recombin
virus
contain
mutat
alon
contain
mutat
alon
highli
virul
virus
mutat
gene
show
high
virul
indic
virul
sarscov
determin
multipl
gene
similar
observ
report
weiss
laboratori
mhv
infect
report
major
determin
neurovirul
mhvjhm
strain
gene
outsid
also
involv
virul
mouseadapt
frmo
use
present
studi
amino
acid
chang
well
compar
nonvirul
strain
although
analysi
use
recombin
virus
yet
done
result
good
agreement
observ
robert
et
al
term
involv
multigen
pathogen
sarscov
present
studi
suggest
involv
elastas
develop
sever
pneumonia
caus
sarscov
infect
elucid
cultur
cell
matsuyama
et
al
elastas
could
enhanc
sarscov
replic
lung
altern
elastas
could
involv
develop
sever
respiratori
diseas
via
pathophysiolog
function
proteolyt
activ
enhanc
blood
vessel
permeabl
induct
proinflammatori
cytokin
secret
activ
elastas
produc
lung
report
respons
acut
lung
injuri
howev
elastas
alon
respons
sever
respiratori
diseas
describ
present
studi
sinc
mice
infect
pp
alon
develop
sever
respiratori
diseas
although
induc
much
elastas
product
pp
frmo
infect
thu
extens
infect
sarscov
lung
could
contribut
develop
sever
respiratori
diseas
studi
use
elastas
inhibitor
antielastas
antibodi
progress
see
whether
elastas
involv
pathogenesi
sar
least
two
mechan
propos
explain
high
pathogenesi
sar
name
induct
sever
lung
injuri
imai
et
al
describ
sarscov
receptor
play
import
role
prevent
histopatholog
immunohistochem
studi
lung
infect
pp
andor
sarscov
exud
hyalin
substanc
alveolar
caviti
infiltr
macrophag
lymphocyt
alveolar
wall
hyperplast
chang
type
respiratori
epitheli
cell
observ
mice
coinfect
withpp
frmo
day
exud
alveoli
found
mice
infect
frmo
alon
b
also
viral
antigen
brown
seen
cytoplasm
respiratori
epitheli
cell
arrow
mice
infect
withpp
frmo
day
four
c
lung
lesion
mous
die
day
four
infect
bypp
frmo
similar
seen
case
diffus
alveolar
damag
character
exud
hyalin
membran
arrow
alveolar
caviti
e
antigen
detect
rabbit
hyperimmun
serum
sarscov
use
diaminobentizin
visual
hematoxylin
counterstain
c
hematoxylin
eosin
other
routin
stain
origin
magnif
b
c
e
lung
damag
edema
convert
angiotensin
ii
lung
damag
activ
less
damag
angiotensin
sarscov
replic
lung
known
downregul
result
increas
angiotensin
ii
lung
injuri
anoth
mechan
sever
lung
injuri
caus
cytokin
chemokin
produc
result
sarscov
infect
sever
differ
anim
model
show
high
concentr
inflammatori
cytokin
could
respons
pathogenesi
sar
present
studi
hypothesi
high
replic
sarscov
presum
due
presenc
proteas
enhanc
sarscov
infect
respons
pathogenesi
sar
contradict
two
propos
mechan
sar
pathogenesi
sinc
high
replic
result
greater
downregul
lung
also
induc
higher
c
societi
blackwel
publish
asia
pti
ltd
cytokin
product
shown
present
studi
believ
mechan
underli
higher
replic
viru
lung
could
primari
import
induct
sar
mortal
rate
sar
victim
report
approxim
age
peopl
suffer
chronic
heart
renal
diseas
diabet
shown
extrem
prone
infect
individu
suppos
suscept
varieti
infecti
agent
normal
fail
affect
ordinari
healthi
individu
possibl
exacerb
sar
peopl
could
attribut
coinfect
nonor
lowpathogen
agent
mycoplasma
chlamydia
like
although
agent
often
isol
patient
lung
howev
impli
agent
intensifi
effect
sar
sinc
possibl
may
induc
mild
inflamm
trigger
sarscov
high
replic
fail
grow
lung
may
infer
find
present
studi
pp
infect
exacerb
sarscov
infect
multipli
effici
lung
mice
monkey
highli
suscept
gener
sarscov
though
report
develop
sarslik
sever
respiratori
diseas
differ
suscept
might
attribut
part
least
environment
condit
monkey
grow
maintain
experi
hypothesi
could
also
explain
small
laboratori
anim
mice
rat
appear
suscept
sarscov
infect
anim
kept
clean
sens
purpos
expos
mani
microorgan
laboratori
set
howev
anim
first
contamin
microorgan
normal
virul
grow
initi
mild
inflamm
respiratori
organ
may
becom
sensit
sarscov
infect
summari
demonstr
pneumonia
caus
sarscov
infect
exacerb
coinfect
lowpathogen
bacterium
excel
anim
model
sar
extraordinarili
import
develop
vaccin
antiviru
drug
well
sar
pathogenesi
studi
